Organogenesis (ORGO)
(Delayed Data from NSDQ)
$2.91 USD
-0.04 (-1.36%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $2.90 -0.01 (-0.34%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth B Momentum C VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Bottom 37% (151 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.52 | 9.99 |
Current Quarter Estimate | -0.02 | -2.04 | 61.00 |
Year Ago Quarter Estimate | 0.04 | -0.59 | 54.84 |
Next Quarter Estimate | 0.01 | -2.00 | 63.00 |
Next Year Estimate | -0.03 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -250.00 | 13.90 | 15.67 |
Next Year | 50.00 | 15.60 | 9.31 |
Last 5 Years | NA | 7.00 | 8.10 |
Next 5 Years | NA | 25.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 73.75 | -5.88 |
Price/Book (MRQ) | 1.40 | 1.67 |
Price/Cash Flow (MRFY) | 13.72 | 8.16 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 1.34% | -2,822.50% |
Return on Equity (TTM) | 2.11% | -71.77% |
Debt to Equity (MRQ) | NA | 0.08 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.